Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.
A grade PMID 42321916
View analysis →A grade PMID 42372741
View analysis →A grade PMID 42216567
View analysis →A grade PMID 41916649
View analysis →A grade PMID 42382416
View analysis →A grade PMID 42150584
View analysis →A grade PMID 41756844
View analysis →A grade PMID 42362103
View analysis →A grade PMID 42101908
View analysis →A grade PMID 42248607
View analysis →A grade PMID 41667193
View analysis →A grade PMID 42260111
View analysis →This case report describes successful complete excision of a giant Todani type IA choledochal cyst with Roux-en-Y hepaticojejunostomy in a 78-year-old woman after failed endoscopic biliary intervention, with a favorable postoperative course and no malignancy on histopathology.
The reported evidence shows technical success in one elderly patient; it supports only the hypothesis that cyst excision with Roux-en-Y hepaticojejunostomy may provide definitive management when endoscopic intervention fails, not that this approach improves oncologic or pediatric outcomes broadly.
This case report describes a 12-year-old girl with recurrent sterile inflammatory bone lesions diagnosed as chronic recurrent multifocal osteomyelitis after imaging and histopathologic evaluation, with physeal damage leading to limb-length discrepancy.
The reported case supports early recognition and multidisciplinary diagnostic evaluation to reduce unnecessary antibiotics and invasive procedures; it can only be inferred—not established here—that earlier control of inflammation might help prevent irreversible skeletal complications because no specific treatment or treatment response is reported.
This case report describes a 52-year-old man with a small papillary thyroid carcinoma and a separate large lateral-neck angiomatoid fibrous histiocytoma initially suspected to be nodal metastasis, with no clinical neck recurrence at one year after surgical treatment.
The record provides no evidence for a new anticancer therapy; it supports the diagnostic observation that independently sampling anatomically distinct or disproportionate lesions may distinguish synchronous tumors from metastatic disease, with the inferred potential to improve surgical planning and avoid treatment based on incorrect staging.
This case report describes a 7-year-old girl with histopathologically confirmed buccal mucosal lobular capillary haemangioma that was surgically excised without recurrence during six months of follow-up.
The record provides case-level evidence that local surgical excision can control a buccal LCH; it does not establish comparative efficacy, broader safety, a novel therapeutic strategy, or applicability to malignant pediatric disease.
This case report describes a 14-year-old boy with a small transverse-colon juvenile polyp whose histology unexpectedly showed rare osseous metaplasia after uncomplicated polypectomy.
The record provides no evidence for a therapeutic strategy; at most, it supports the hypothesis that recognizing osseous metaplasia in pediatric polyps could aid pathological classification or future surveillance research, but its prognostic and treatment implications remain unknown.
This case report describes an adult colon-cancer survivor who, after left hemicolectomy and approximately three years and five months of disease-free follow-up, had an uncomplicated pregnancy and term cesarean delivery of a healthy neonate.
The reported evidence shows reproductive feasibility in one carefully selected adult survivor; it supports the hypothesis that pregnancy may be possible after curative colon-cancer surgery and confirmed disease-free follow-up with multidisciplinary care, but it does not establish pregnancy safety, recurrence risk, or a therapeutic intervention.
This case report describes a newborn with a clinically diagnosed preputial cyst who was successfully treated by circumcision and discusses the lesion as a rare form of median raphe cyst.
Evidence: circumcision successfully treated the cyst in this single newborn, while the abstract states that surgical excision is generally the treatment of choice. Inference: recognition of this benign-appearing lesion could support appropriate local surgical management and avoid diagnostic confusion, but the record provides no pediatric-oncology therapeutic hypothesis or comparative evidence.
Using GLOBOCAN 2022 estimates, the study describes global and regional cancer incidence and mortality across sex and age bands, finding substantial geographic disparities and disproportionately high mortality in younger populations within transitioning regions.
The record provides no direct therapeutic evidence; it supports the inference that age-, sex-, and region-specific allocation of early-detection and treatment resources might reduce disparities, including those affecting younger patients, but this requires intervention-based testing.
Using GBD 2021 estimates for 204 countries and territories, the study reports rising global CNS cancer incidence and prevalence from 1990 to 2021, declining age-standardized DALY rates, substantial socioeconomic disparities, and scenario-based projections of future burden.
The record provides no evidence for a specific therapy; it supports the inference that directing diagnostic, treatment, survivorship, and health-system resources toward high-DALY and lower-SDI populations could help reduce inequities in CNS cancer outcomes, but this was not tested and pediatric-specific benefit is not demonstrated.
This Global Burden of Disease analysis reports increasing worldwide thyroid-cancer incidence, prevalence, deaths, DALYs, and socioeconomic inequalities from 1990 to 2021, with case counts projected to continue rising through 2045.
The evidence supports population growth, aging, and widening cross-country inequalities as contributors to thyroid-cancer burden; it is reasonable but untested to infer that more equitable resource allocation and cancer-control planning could improve outcomes, as no therapeutic or preventive intervention was evaluated.
This area-level composite topsoil study found differing urban and rural metal(loid) patterns around Leicester, with precautionary screening calculations indicating child hazard indices above unity mainly from arsenic but no measured human exposure, cancer outcome, or pediatric-oncology endpoint.
The record provides no therapeutic hypothesis or treatment evidence; at most, it supports the inference that confirmatory exposure assessment could identify environmental risk-management opportunities for children, but any relevance to cancer prevention is untested.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 96.2/100. Study design: 100.0; human relevance: 100.0; therapeutic relevance: 96.0; sample size: 70.0; recency: 100.0; abstract quality: 100.0.
